Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$GEVO, just loaded more 1.37's
$GEVO 1.36, strange it's down after closing the offering and now the company is cashed up, thinking this springs up today
$HTBX looking good early,picked up some at 1.35 yesterday, wish I loaded more now, Good Morning !
$GEVO,yep, I think alot of people just see offering in the headline and think it's bad not realizing it's over and now the company is all cashed up, should be up from here
$GEVO News Link >> Gevo, Inc. Announces Closing of $50 Million Registered Direct Offering
https://finance.yahoo.com/news/gevo-inc-announces-closing-50-200100354.html
$GEVO, nice, just added
$MNKD 1.83 hod
$BBI, up some off lows, crazy it's not up Big off $5 target by Oppenheimer today,small O/S maybe someone getting out of a position or a delayed reaction,anyway loaded more in .85 to .89 range,think it should run at some point
https://twitter.com/PJ_Matlock/status/1298309573640691713
$IDEX 1.30 , hod
$IDEX, soon or later and I think sooner it is gonna have a epic move
$IBIO hod 2.74
$BBI on the move with a $5 Target out by Oppenheimer to Outperform
$BBI 1.09
$BBI making a move
$VIVE , wow +145%
$GEVO & $IBIO looking good
$CAPR News out ! >> Capricor Therapeutics Announces U.S. FDA Acceptance of its IND Application for a Phase 2 Clinical Trial of CAP-1002 in Patients with COVID-19
https://www.globenewswire.com/news-release/2020/08/25/2083335/0/en/Capricor-Therapeutics-Announces-U-S-FDA-Acceptance-of-its-IND-Application-for-a-Phase-2-Clinical-Trial-of-CAP-1002-in-Patients-with-COVID-19.html
$BBI, in for a starter @ $1, $5 target, Outperform from Oppenheimer
- https://www.dispatchtribunal.com/2020/08/25/oppenheimer-initiates-coverage-on-brickell-biotech-nasdaqbbi.html
$UONE, damn saw this creeping up early on watchlist, could have grabbed high $4's, in 8's now, shows 11.95 hod, other black banks popping too, $UONEK , $CARV , $BYFC, not sure why
Yeah, I don't get it
$TORC , A Heads up,I'm out this morning, received email this morning for their Meeting and Proxy vote,they are wanting to do a RS of 4 for 1 for 12 for 1, I like the company but will wait for reentry after RS possibly or is they cancel it
Determination of Reverse Stock Split Ratio
The ratio of the reverse stock split, if approved by the resTORbio stockholders and implemented by the
resTORbio Board, will be between 1-for-4 and 1-for-12 shares outstanding, as determined by the resTORbio
Board and agreed to by Adicet. If the resTORbio Board determines to proceed with the reverse stock split,
resTORbio will publicly announce the exact ratio selected. In determining the reverse stock split ratio, the
resTORbio Board will consider numerous factors including:
• the historical and projected performance of resTORbio common stock before and after the reverse
stock split;
• prevailing industry, general economic and market conditions;
• the projected impact of the selected reverse stock split ratio on trading liquidity in resTORbio common
stock and resTORbio’s ability to continue its common stock’s listing on Nasdaq (See “Matters Being
Submitted to a Vote of resTORbio Stockholders—Nasdaq Requirements for Listing on the Nasdaq
Global Select Market” beginning on page 239 of this proxy statement/prospectus/information
statement);
• resTORbio’s capitalization (including the number of shares of resTORbio common stock issued and
outstanding);
• the prevailing trading price for resTORbio common stock and the volume level thereof; and
• potential devaluation of resTORbio’s market capitalization as a result of a reverse stock split.
The purpose of asking for authorization to implement a reverse stock split at a ratio to be determined by the
resTORbio Board, as opposed to a ratio fixed in advance, is to give the resTORbio Board the flexibility to take
into account then-current market conditions and changes in price of resTORbio common stock and to respond to
other developments that may be deemed relevant, when considering the appropriate ratio.
$GEVO, good chance this could head over $2 this week
$IBIO looking Strong !
$GEVO - 1.50
Spac's doing well today, $SHLL , $FMCI , $LCA , $DPHC , $SPAQ ..keep a eye on $CCXX too,I'm gonna get some more myself
$FMCI 17.95 hod
LOL, the good stuff
Yes, I like $CGC & $CRON alot too, they have big $$ behind them, I think alot of them learned from their mistakes since they first came out
$SHLL - $40
Coming up on CNBC a analyst is gonna talk about how he's bullish on weed stocks,...I've loaded more myself today - $CGC , $TLRY , $CRON , $ACB & $APHA...I think the sector is gonna get real hot so trying to be ahead of the curve, the states are gonna need new streams of revenue bad
$BLNK , I just think people are realizing that those hit pieces that were out last week were alot of bullchit and getting back in,I loaded some more earlier this morning
LMAO,thought the same thing
$ONTX, would have been a good grab under .30
$BLNK moving, 7.40 , hod
$LCA looking good too, loaded more $DPHC & $SPAQ too today
$SHLL 38.50 !
$IBIO 2.49 hod
$IBIO 2.32